GLP-1RA: New Hope in Obesity Therapy
Danfeng Zhang, Hongyun Lu
openaire +1 more source
Racial and demographic disparities in glp-1ra use among breast cancer patients with Type 2 Diabetes. [PDF]
Hundal J +5 more
europepmc +1 more source
Effectiveness of GLP-1RA according to different type 2 diabetes phenotypes: A retrospective study. [PDF]
Caruso I +9 more
europepmc +1 more source
Optimising GLP-1RA Efficacy: A Meta-Analysis of Baseline Age and HbA1c as Predictors of MACE Reduction in T2DM. [PDF]
Ghosal S, Ghosal A.
europepmc +1 more source
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching. [PDF]
Choi J +9 more
europepmc +1 more source
<i>Alea Iacta Est</i>: Casting the Die in Favor of Evidence-Based, Rational GLP-1RA Use. [PDF]
Belančić A.
europepmc +1 more source
GLP-1RA in JBMMSCs promoted osteogenic differentiation via modulating CREB and BRD4 signaling mediated proliferation and stemness. [PDF]
Liu H, Tian Y, Bao X, Li Y.
europepmc +1 more source
Long-acting management of diabetes and associated complications using an injectable thermosensitive hydrogel incorporating IgG-conjugated GLP-1RA. [PDF]
Wang H +9 more
europepmc +1 more source
Information pharmacists assist in the construction of GLP-1RA prescription review rules in a tertiary hospital in China. [PDF]
Zhou L +5 more
europepmc +1 more source
Cancer risk with GLP-1RA: what can real-world data really tell us? [PDF]
Jessen N, Støvring H.
europepmc +1 more source

